World's Best Scientists 2026 revealed!
VIEW LIST
Adriano Lazzarin

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 105 589 543 15 13 898 43097
Medicine 105 6739 6337 223 209 913 43222

Adriano Lazzarin publications per year

The chart shows the history of publications by Adriano Lazzarin between 1975 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Adriano Lazzarin published across 51 years, from 1975 to 2025, averaging 18.3 papers a year. Output peaked at 40 publications in 2000. 12 of the 933 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1975 to 2025. Vertical axis: number of publications, 0 to 40. Peak 40 publications in 2000. 1975: 4 publications 1976: 2 publications 1977: 3 publications 1978: 1 publication 1979: 4 publications 1980: 1 publication 1981: 4 publications 1982: 6 publications 1983: 2 publications 1984: 16 publications 1985: 18 publications 1986: 15 publications 1987: 20 publications 1988: 19 publications 1989: 17 publications 1990: 17 publications 1991: 28 publications 1992: 16 publications 1993: 12 publications 1994: 30 publications 1995: 21 publications 1996: 16 publications 1997: 31 publications 1998: 14 publications 1999: 17 publications 2000: 40 publications 2001: 21 publications 2002: 27 publications 2003: 33 publications 2004: 30 publications 2005: 29 publications 2006: 32 publications 2007: 32 publications 2008: 31 publications 2009: 26 publications 2010: 29 publications 2011: 23 publications 2012: 26 publications 2013: 27 publications 2014: 35 publications 2015: 28 publications 2016: 20 publications 2017: 31 publications 2018: 24 publications 2019: 12 publications 2020: 13 publications 2021: 11 publications 2022: 3 publications 2023: 4 publications 2024: 5 publications 2025: 7 publications
1975 2025

933 publications in total across all disciplines

View publications per year as a table
Adriano Lazzarin: publications per year, 1975 to 2025
Year Publications
1975 4
1976 2
1977 3
1978 1
1979 4
1980 1
1981 4
1982 6
1983 2
1984 16
1985 18
1986 15
1987 20
1988 19
1989 17
1990 17
1991 28
1992 16
1993 12
1994 30
1995 21
1996 16
1997 31
1998 14
1999 17
2000 40
2001 21
2002 27
2003 33
2004 30
2005 29
2006 32
2007 32
2008 31
2009 26
2010 29
2011 23
2012 26
2013 27
2014 35
2015 28
2016 20
2017 31
2018 24
2019 12
2020 13
2021 11
2022 3
2023 4
2024 5
2025 7
Total 933
Download as CSV

Adriano Lazzarin publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Adriano Lazzarin sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 807+ publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 898 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100 898
Download as CSV

Adriano Lazzarin D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Adriano Lazzarin sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 104–105 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 105 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54 105
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Adriano Lazzarin is affiliated with Vita-Salute San Raffaele University in Italy. Their scholarly work primarily spans the field of Medicine, with a distinct focus on Infectious Diseases, Virology, Emergency Medicine, Epidemiology, and Hepatology.

Their research topics include:

  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV-related health complications and treatments
  • Hepatitis C virus research
  • COVID-19 Clinical Research Studies
  • Pharmacological Effects and Toxicity Studies

Recent publications from Adriano Lazzarin reveal a focus on infectious disease management and COVID-19 clinical research. Selected recent papers include:

  • "Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors" (2020), published in Clinical Microbiology and Infection
  • "Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy" (2020), published in Clinical Immunology
  • "Candidemia in Coronavirus Disease 2019 (COVID-19) Patients: Incidence and Characteristics in a Prospective Cohort Compared With Historical Non-COVID-19 Controls" (2020), published in Clinical Infectious Diseases
  • "Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial" (2021), published in The Lancet HIV
  • "Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19" (2020), published in Scientific Reports

Frequent coauthors of Adriano Lazzarin include:

  • Antonella Castagna
  • Antonella d'Arminio Monforte
  • Andrea Antinori
  • Nicola Gianotti
  • Laura Galli

Adriano Lazzarin has contributed multiple publications to several prominent journals, notably:

  • Journal of Antimicrobial Chemotherapy
  • Open Forum Infectious Diseases
  • UNC Libraries
  • Clinical Infectious Diseases
  • AIDS

Best Publications

  • Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.

    Francesca J. Torriani;Maribel Rodriguez-Torres;Jürgen K. Rockstroh;Eduardo Lissen

  • Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

    Roy T. Steigbigel;David A. Cooper;Princy N. Kumar;Joseph E. Eron

  • Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia.

    Adriano Lazzarin;Bonaventura Clotet;David Cooper;Jacques Reynes

  • Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

    Jeffrey L. Lennox;Edwin DeJesus;Adriano Lazzarin;Richard B. Pollard

  • Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

    Adriano Lazzarin;Thomas Campbell;Bonaventura Clotet;Margaret Johnson

  • Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

    Beatriz Grinsztejn;Bach Yen Nguyen;Christine Katlama;Jose M. Gatell

  • Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

    Bonaventura Clotet;Nicholas Bellos;Jean Michel Molina;David Cooper

  • Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.

    David A. Cooper;Roy T. Steigbigel;Jose M. Gatell;Jurgen K. Rockstroh

  • Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trial

    Jean Michel Molina;Pedro Cahn;Beatriz Grinsztejn;Adriano Lazzarin

  • Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from the ASSERT Study

    Hans-Jürgen Stellbrink;Chloe Orkin;Jose Ramon Arribas;Juliet Compston

  • Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

    Gerd Fätkenheuer;Mark Nelson;Adriano Lazzarin;Irina Konourina

  • Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials

    Charles B Hicks;Pedro Cahn;David A Cooper;Sharon L Walmsley

  • The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years

    Mark R. Nelson;Christine Katlama;Julio S. Montaner;David A. Cooper

  • Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

    Unknown

  • Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial

    Joel Gallant;Adriano Lazzarin;Anthony Mills;Chloe Orkin

  • Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

    Antonella Castagna;Franco Maggiolo;Giovanni Penco;David Wright

  • Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system

    P. Cinque;M. Brytting;B. Wahren;A. Linde

  • Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.

    Kathleen Squires;Adriano Lazzarin;José M. Gatell;William G. Powderly

  • Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

    Joseph J. Eron;Bonaventura Clotet;Jacques Durant;Christine Katlama

  • Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.

    Margaret Johnson;Beatriz Grinsztejn;Claudia Rodriguez;Jeffrey Coco

  • The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia

    Giuseppe Pantaleo;James F. Demarest;Timothy Schacker;Mauro Vaccarezza

  • Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.

    Marco Ripa;Laura Galli;Andrea Poli;Chiara Oltolini

  • A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection

    Sabine Kinloch De Loës;Bernard J. Hirschel;Bruno Hoen;David A. Cooper

  • Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial

    Unknown

Frequent Co-Authors

Antonella Castagna
Antonella Castagna Vita-Salute San Raffaele University
Giuseppe Tambussi
Giuseppe Tambussi Vita-Salute San Raffaele University
Paola Cinque
Paola Cinque Vita-Salute San Raffaele University
Massimo Galli
Massimo Galli University of Milan
Mauro Moroni
Mauro Moroni University of Milan
Guido Poli
Guido Poli Vita-Salute San Raffaele University
Massimo Clementi
Massimo Clementi Vita-Salute San Raffaele University
Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan
Andrea Antinori
Andrea Antinori Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Cristina Mussini
Cristina Mussini University of Modena and Reggio Emilia

External Links

Personal website of Adriano Lazzarin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can broaden career opportunities within healthcare and research fields. Accelerated nursing programs, such as accelerated np programs, provide a fast track to becoming a Nurse Practitioner, combining clinical skills with immunology knowledge to treat patients effectively.

Individuals without a nursing background can still enter the field through online ABSN programs for non nurses, which allow direct entry into nursing with flexible, accessible coursework tailored for career changers. These programs can complement immunology studies with foundational healthcare training.

For those seeking less competitive entry points, options like the easiest accelerated nursing programs offer accessible pathways to earn a Bachelor of Science in Nursing quickly and efficiently while gaining exposure to immunological principles applicable in many clinical settings.

Additionally, starting with practical nursing credentials from LPN schools easy to get into can provide valuable hands-on experience. Licensed Practical Nurses often work closely with immunologists and researchers, gaining insights that can guide future advanced education.

Best Scientists Citing Adriano Lazzarin

Vincent Soriano

Vincent Soriano

Universidad Internacional De La Rioja

Publications: 128

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 124

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 121

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 117

David A. Cooper

David A. Cooper

University of New South Wales

Publications: 97

Andrea Antinori

Andrea Antinori

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Publications: 89

Dominique Costagliola

Dominique Costagliola

Inserm

Publications: 83

Antonella d'Arminio Monforte

Antonella d'Arminio Monforte

University of Milan

Publications: 82

Carlo Federico Perno

Carlo Federico Perno

University of Milan

Publications: 81

Christine Katlama

Christine Katlama

Sorbonne University

Publications: 81

Caroline Sabin

Caroline Sabin

University College London

Publications: 80

Pere Domingo

Pere Domingo

Autonomous University of Barcelona

Publications: 80

Paul E. Sax

Paul E. Sax

Brigham and Women's Hospital

Publications: 80

José M. Gatell

José M. Gatell

University of Barcelona

Publications: 77

David C. Montefiori

David C. Montefiori

Duke University

Publications: 74

Guido Poli

Guido Poli

Vita-Salute San Raffaele University

Publications: 73

Trending Scientists

Wenzhuo Wu

Wenzhuo Wu

Purdue University West Lafayette

Javier Simón-Sánchez

Javier Simón-Sánchez

University of Tübingen

Bechir Hamdaoui

Bechir Hamdaoui

Oregon State University

Jan L. Wallander

Jan L. Wallander

University of California, Merced

Cheryl A. Bopp

Cheryl A. Bopp

Centers for Disease Control and Prevention

Gaute Lavik

Gaute Lavik

Max Planck Society

Gayle S.W. Hagler

Gayle S.W. Hagler

Environmental Protection Agency

Melinda S. Peng

Melinda S. Peng

United States Naval Research Laboratory

Oliver Billker

Oliver Billker

Umeå University

Geoffrey Neale

Geoffrey Neale

St. Jude Children's Research Hospital

Chuguang Zheng

Chuguang Zheng

Huazhong University of Science and Technology

Daqing Zhang

Daqing Zhang

Peking University

Eric Raymond

Eric Raymond

St. Joseph Hospital

Takashi Abe

Takashi Abe

University of Mississippi

Wolfgang Böhme

Wolfgang Böhme

Leibniz Association

Tim Coulson

Tim Coulson

University of Oxford

Related Immunology Rankings & Guides

2027 Best LPN Programs in New Jersey – Accredited Online LPN Programs

2027 Best LPN Programs in New Jersey – Accredited Online LPN Programs
2027 Best LPN Programs in South Carolina – Accredited Online LPN Programs

2027 Best LPN Programs in South Carolina – Accredited Online LPN Programs
Best Direct-Entry MSN Programs in Texas: Online & Campus for 2027

Best Direct-Entry MSN Programs in Texas: Online & Campus for 2027
2027 Best BSN to MSN Programs in Minnesota: Online & Campus

2027 Best BSN to MSN Programs in Minnesota: Online & Campus
2027 Best ADN-to-MSN (RN-to-NP) Bridge Programs

2027 Best ADN-to-MSN (RN-to-NP) Bridge Programs
2027 Best CNA to LPN Bridge Programs Online

2027 Best CNA to LPN Bridge Programs Online
2027 Best Master’s in Medical Science Programs

2027 Best Master’s in Medical Science Programs
2027 Best Accelerated Online Bachelor's in Health Sciences Programs

2027 Best Accelerated Online Bachelor's in Health Sciences Programs
2027 Best ADN Nursing Programs in Texas: Online & Campus

2027 Best ADN Nursing Programs in Texas: Online & Campus
2027 Best ABSN Programs - List of Accelerated BSN Programs in Washington: Online & Campus

2027 Best ABSN Programs - List of Accelerated BSN Programs in Washington: Online & Campus
September 2027 Best 1-Year Nurse Practitioner Online Programs

September 2027 Best 1-Year Nurse Practitioner Online Programs
2027 Best Accelerated Paramedic to RN Online Bridge Programs

2027 Best Accelerated Paramedic to RN Online Bridge Programs
2027 Best LPN Programs in Minnesota – Accredited Online LPN Programs

2027 Best LPN Programs in Minnesota – Accredited Online LPN Programs
2027 Best LPN Programs in North Carolina – Accredited Online LPN Programs

2027 Best LPN Programs in North Carolina – Accredited Online LPN Programs
2027 Best Medical Assistant to LPN Programs Online

2027 Best Medical Assistant to LPN Programs Online
2027 Best Accelerated Nurse Practitioner NP Online Programs

2027 Best Accelerated Nurse Practitioner NP Online Programs
2027 Best 12-Month FNP Programs (Online & Campus)

2027 Best 12-Month FNP Programs (Online & Campus)
2027 Best Medical Transcription Courses Online

2027 Best Medical Transcription Courses Online
2027 Best LPN Programs in Missouri – Accredited Online LPN Programs

2027 Best LPN Programs in Missouri – Accredited Online LPN Programs
2027 Best ABSN Programs - Accelerated BSN Programs in Georgia: Online & Campus

2027 Best ABSN Programs - Accelerated BSN Programs in Georgia: Online & Campus
2027 Best Accelerated Online Nurse Executive Leadership MSN Programs

2027 Best Accelerated Online Nurse Executive Leadership MSN Programs

Recently Published Articles

2027 How to Become a History Teacher in Connecticut: Requirements & Certification

2027 How to Become a History Teacher in Connecticut: Requirements & Certification
2027 How to Become a Nurse Navigator: Education, Salary, and Job Outlook

2027 How to Become a Nurse Navigator: Education, Salary, and Job Outlook
2027 What Can You Do with a Criminal Justice Degree? Costs and Job Opportunities

2027 What Can You Do with a Criminal Justice Degree? Costs and Job Opportunities
2027 APRN vs. PA: Explaining the Difference

2027 APRN vs. PA: Explaining the Difference
2027 Hardest and Easiest Courses in a Geoscience Degree Program

2027 Hardest and Easiest Courses in a Geoscience Degree Program
2027 Best Online Clinical Master of Social Work (LCSW) Programs

2027 Best Online Clinical Master of Social Work (LCSW) Programs
2027 Low-Cost Online MSW Programs That Qualify for Federal Financial Aid

2027 Low-Cost Online MSW Programs That Qualify for Federal Financial Aid
2027 Online Mathematics Master's Programs at Accredited U.S. Universities

2027 Online Mathematics Master's Programs at Accredited U.S. Universities
2027 Best Accredited Online Respiratory Care Therapy Degree Programs: Compare Tuition, Admissions, and Career Outcomes

2027 Best Accredited Online Respiratory Care Therapy Degree Programs: Compare Tuition, Admissions, and Career Outcomes
2027 How to Become a Social Worker in Texas

2027 How to Become a Social Worker in Texas
2027 Online Speech Pathology Degree Programs for Veterans: GI Bill Benefits, Costs & Top Considerations

2027 Online Speech Pathology Degree Programs for Veterans: GI Bill Benefits, Costs & Top Considerations
2027 Biotechnology Degree Careers Ranked by Salary, Growth, and Work-Life Balance

2027 Biotechnology Degree Careers Ranked by Salary, Growth, and Work-Life Balance
2027 Online Health Administration Doctorate Programs with Specializations: Concentrations, Tracks, and Career Paths

2027 Online Health Administration Doctorate Programs with Specializations: Concentrations, Tracks, and Career Paths
2027 Online Human Services Degree Programs With No Personal Statement or Admissions Essay Required

2027 Online Human Services Degree Programs With No Personal Statement or Admissions Essay Required
2027 Cheapest Online Photography Master's Degrees That Pay Well: Tuition, Duration, and Earnings

2027 Cheapest Online Photography Master's Degrees That Pay Well: Tuition, Duration, and Earnings
2027 AI Bachelor's Degrees for Business Professionals

2027 AI Bachelor's Degrees for Business Professionals
2027 Highest Paying Careers With an English Bachelor's Degree

2027 Highest Paying Careers With an English Bachelor's Degree
2027 How to Become a Caregiver: Certification Requirements in California

2027 How to Become a Caregiver: Certification Requirements in California
2027 How to Become a Nurse Practitioner in Newark, NJ: Requirements & Salary

2027 How to Become a Nurse Practitioner in Newark, NJ: Requirements & Salary
2027 What Does a Business Operations Manager Do: Responsibilities, Requirements, and Salary

2027 What Does a Business Operations Manager Do: Responsibilities, Requirements, and Salary
2027 How to Become a Middle School Math Teacher in Kentucky: Requirements & Certification

2027 How to Become a Middle School Math Teacher in Kentucky: Requirements & Certification